Meet Our People

Our Leadership

In a short period of time, TransCelerate has achieved unprecedented progress, delivering tangible impact to benefit the broader biopharmaceutical industry. All this would not have been achievable without the active engagement and sponsorship from some of the most senior leaders in the industry.

In just a few years, our leaders have made significant strides toward our goal of making clinical development more efficient. TransCelerate leadership has an unwavering dedication to assessing, refining and creating processes to make the drug development environment efficient, safe and innovative.

Leadership Profiles

Chief Executive Officer

Dalvir Gill
Chief Executive Officer, TransCelerate BioPharma Inc.


Andy Lee (Treasurer)
Senior Vice President, Head of Global Clinical Trial Operations, Merck
Lynn Marks (Secretary and Chair of the Oversight Committee)
Senior Vice President, Projects, Clinical Platforms & Sciences, GlaxoSmithKline

Board of Directors Leadership

Iris Loew-Friedrich (Chair of the Board)
Executive Vice President, Biopharma Development Solutions and Chief Medical Officer, UCB
Corsee Sanders (Vice Chair of the Board)
Senior Vice President, Global Head of Product Development Innovation & Clinical Operations, Roche

Board of Directors

Alise Reicin
Senior Vice President, Head of Global Clinical Development, EMD Serono, Inc.
Bernhardt Zeiher
President, Global Development, Astellas Pharma
Christopher Corsico
Senior Vice President, Corporate Division Medicine and Chief Medical Officer, Boehringer Ingelheim GmbH
David Nicholson
Executive Vice President, Brands Research & Development, Allergan
Elias Zerhouni
President of Global R&D, Sanofi
Elliott Levy
Senior Vice President, Global Development, Amgen
Jan Lundberg
Executive Vice President of Science and Technology, Eli Lilly & Co.
Michael Severino
Executive Vice President, Chief Scientific Officer, AbbVie
Patrick Vallance
President, Pharmaceuticals R&D, GlaxoSmithKline
Patrizia Cavazzoni
Senior Vice President, Worldwide Head of Development Operations, Pfizer
Paul Stoffels
Chief Scientific Officer, Worldwide Chairman of Pharmaceuticals, Johnson & Johnson
Peter Kristensen
Senior Vice President, Global Development, Novo Nordisk A/S
Peter Ronco
Vice President, Global Clinical Operations, Bristol Myers Squibb
Roy Baynes
Senior Vice President, Global Clinical Development, Merck Research Laboratories
Sean Bohen
Executive Vice President, Global Medicines Development, and Chief Medical Officer, AstraZeneca Pharmaceuticals
Takuko Sawada
Senior Executive Officer, Executive General Manager, Global Development, Shionogi & Co., Ltd.

Senior Vice President, Global Operations

Janice Chang
Senior Vice President, Global Operations, TransCelerate BioPharma, Inc.

Translate »